Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients

In order to identify biomarkers for earlier prediction of COVID-19 outcome, we collected blood samples from patients with fatal outcomes (non-survivors) and with positive clinical outcomes (survivors) at ICU admission and after seven days. COVID-19 survivors and non-survivors showed significantly di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kattner, Simone, Müller, Jan, Glanz, Karolina, Manoochehri, Mehdi, Sylvester, Caroline, Vainshtein, Yevhen, Berger, Marc Moritz, Brenner, Thorsten, Sohn, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019437/
https://www.ncbi.nlm.nih.gov/pubmed/36928077
http://dx.doi.org/10.1038/s41598-023-30158-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019437/
https://www.ncbi.nlm.nih.gov/pubmed/36928077
http://dx.doi.org/10.1038/s41598-023-30158-1

Ejemplares similares